European guidelines for personality disorders: past, present and future

[1]  A. Chapman.  Borderline personality disorder and emotion dysregulation , 2019, Development and Psychopathology.

[2]  L. Mehlum.  DBT as a Suicide and Self-harm Treatment , 2018 .

[3]  S. Doering,et al.  Changes in Attachment Representation in Psychotherapy: Is Reflective Functioning the Crucial Factor? , 2018, Zeitschrift fur Psychosomatische Medizin und Psychotherapie.

[4]  M. Walter,et al.  Borderline-Störung: Behandlungsempfehlungen der SGPP , 2018, Swiss Archives of Neurology, Psychiatry and Psychotherapy.

[5]  B. Völlm,et al.  Pharmacological interventions for people with borderline personality disorder , 2018 .

[6]  P. Cuijpers,et al.  Efficacy of Psychotherapies for Borderline Personality Disorder: A Systematic Review and Meta-analysis , 2017, JAMA psychiatry.

[7]  J. Gunderson,et al.  Evidence-Based Treatments for Borderline Personality Disorder: Implementation, Integration, and Stepped Care , 2016, Harvard review of psychiatry.

[8]  L. Degenhardt,et al.  The influence of personality disorder on the future mental health and social adjustment of young adults: a population-based, longitudinal cohort study. , 2016, The lancet. Psychiatry.

[9]  J. Boettcher,et al.  Avoidant Personality Disorder: a Current Review , 2016, Current Psychiatry Reports.

[10]  M. Crawford,et al.  Are recommendations for psychological treatment of borderline personality disorder in current U.K. guidelines justified? Systematic review and subgroup analysis. , 2014, Personality and mental health.

[11]  A. Arntz,et al.  Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders. , 2014, The American journal of psychiatry.

[12]  Erik Simonsen,et al.  Psychological therapies for people with borderline personality disorder , 2012 .

[13]  Chin-Kuo Chang,et al.  Life expectancy at birth and all-cause mortality among people with personality disorder. , 2012, Journal of psychosomatic research.

[14]  P. Shekelle,et al.  Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations , 2012, Implementation Science.

[15]  Günter Ollenschläger,et al.  Guidelines International Network: Toward International Standards for Clinical Practice Guidelines , 2012, Annals of Internal Medicine.

[16]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[17]  Rebekah Bourne.  Antisocial Personality Disorder: The NICE Guideline on Treatment, Management and Prevention , 2010, British Journal of Psychiatry.

[18]  G. Rücker,et al.  Pharmacological interventions for borderline personality disorder. , 2010, The Cochrane database of systematic reviews.

[19]  David H Barlow,et al.  The dissemination and implementation of evidence-based psychological treatments. A review of current efforts. , 2010, The American psychologist.

[20]  S. Torgersen,et al.  Personality disorders and quality of life. A population study. , 2006, Comprehensive psychiatry.

[21]  J. Grimshaw,et al.  Potential benefits, limitations, and harms of clinical guidelines , 1999, BMJ.

[22]  Siep Thomas,et al.  Attributes of clinical guidelines that influence use of guidelines in general practice: observational study , 1998, BMJ.

[23]  McDonald Cj,et al.  Guidelines You Can Follow and Can Trust: An Ideal and an Example , 1994 .

[24]  T. Palmstierna,et al.  Personlighetssyndrom, kiniska riktlinjer för utredning och behandling , 2017 .

[25]  G. Rücker,et al.  Psychological therapies for people with borderline personality disorder. , 2012, The Cochrane database of systematic reviews.

[26]  Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. , 2001, The American journal of psychiatry.

[27]  J. Loewenstein.  Clinical practice guidelines. , 1998, International ophthalmology clinics.